Acute Exacerbation of Chronic Obstructive Pulmonary Disease: Pharmacological Treatment of AECOPD New Perspectives

医学 重症监护医学 恶化 慢性阻塞性肺病 叙述性评论 临床试验 疾病 危险分层 心理干预 肺病 慢性阻塞性肺疾病急性加重期 阻塞性肺病 评论文章 梅德林 肺功能测试 肺功能 临床实习 医疗保健 慢性阻塞性肺病加重期 疾病管理 内科学 生活质量(医疗保健)
作者
Jonathan Calvello,Michael Avaricio,Paolo Ruggeri,Antonio Matias Esquinas,Bushra A. Mina
出处
期刊:Seminars in Respiratory and Critical Care Medicine [Thieme Medical Publishers (Germany)]
卷期号:47 (03): 298-307 被引量:2
标识
DOI:10.1055/a-2826-5752
摘要

Abstract: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are major drivers of morbidity, mortality, disease progression, and healthcare utilization worldwide. Evolving definitions of COPD and exacerbations, along with emerging evidence on risk stratification and treatment optimization, have prompted updates in clinical practice, most recently reflected in the 2026 Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines. This review summarizes contemporary perspectives on AECOPD, with a focus on updated definitions, epidemiology, predictors, clinical impact, and current pharmacological and nonpharmacological management strategies, including emerging preventive therapies. A narrative review of published literature, international guidelines, and major clinical trials was conducted, emphasizing evidence relevant to the assessment, treatment, and prevention of AECOPD. Particular attention was given to severity classification and guideline-directed therapeutic approaches. AECOPD is associated with substantial short- and long-term mortality, accelerated lung function decline, increased cardiovascular risk, and high readmission rates. The 2026 GOLD guidelines lower the threshold for high-risk classification, recognizing that even a single moderate exacerbation increases future risk. Acute management remains centered on short-acting bronchodilators, short courses of systemic corticosteroids, and antibiotics when indicated, with treatment of intensity guided by clinical severity and physiological derangements. Adjunctive supportive measures and early postdischarge interventions are critical to improving outcomes. While biologics, macrolides, Roflumilast, and Ensifentrine have no established role in the acute setting, they play an important role in exacerbation prevention as part of individualized, biomarker-informed maintenance strategies. AECOPD should be viewed as a sentinel event that necessitates both effective acute management and reassessment of long-term therapy. Early intervention, severity-based treatment, and postexacerbation optimization of maintenance therapy are essential to reduce recurrence, limit disease progression, and improve survival and quality of life in patients with COPD.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
geejee完成签到,获得积分10
刚刚
李健的小迷弟的应助被木头采纳,获得10
刚刚
1秒前
研友_ZeoKYL完成签到,获得积分10
1秒前
漫漫驳回了Jasper的应助
1秒前
suzy发布了新的文献求助10
2秒前
wangxiaomin发布了新的文献求助10
3秒前
4秒前
4秒前
卡卡完成签到 ,获得积分10
4秒前
XPR发布了新的文献求助10
4秒前
Owen的应助被CMC智能助手采纳,获得10
4秒前
5秒前
5秒前
只争朝夕的应助被cz采纳,获得10
6秒前
十七发布了新的文献求助10
6秒前
7秒前
星星完成签到,获得积分10
7秒前
SunH完成签到,获得积分10
7秒前
follower8107完成签到,获得积分10
8秒前
8秒前
9秒前
SunH发布了新的文献求助10
9秒前
10秒前
烧饼拌糖完成签到,获得积分10
10秒前
魔芋小心发布了新的文献求助10
10秒前
ldxghh发布了新的文献求助10
10秒前
一周八颗蛋完成签到,获得积分10
11秒前
11秒前
12秒前
国度发布了新的文献求助10
12秒前
梵羽发布了新的文献求助10
13秒前
suzy完成签到,获得积分10
13秒前
左白易发布了新的文献求助10
15秒前
16秒前
molihuakai的应助被jack采纳,获得10
16秒前
16秒前
今后的应助被wangxiaomin采纳,获得10
17秒前
俭朴灵竹发布了新的文献求助10
17秒前
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181839
求助须知:如何正确求助?哪些是违规求助? 9571537
关于积分的说明 21818552
捐赠科研通 7778091
什么是DOI,文献DOI怎么找? 3433524
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479621